Randomized Trial: Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Amarin’s Fish-Oil-Derived Drug Shows Great Promise — With Big Caveats – Forbes (free) (via @cardiobrief)

Original Article: Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia – New England Journal of Medicine (free)

“what seriously bothered five of the six cardiologists I spoke to was that the mineral oil had not behaved as a placebo at all.”